Who
Gabriel S. Morris
CFO, President
Company insider
Files Form 4 as: CFO, President, Immix Biopharma.
In numbers
- Trades disclosed
- 27
- Buys
- 8
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Dec 2021
- Last trade
- 22 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 10 Dec 2025filed 10 Dec 2025 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $5,067770 at $6.58 | filing |
| 8 Dec 2025filed 10 Dec 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code X | —96,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code X | —60,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code X | $125K156,000 at $0.80 | filing |
| 16 Sep 2025filed 17 Sep 2025 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $5,1222,600 at $1.97 | filing |
| 20 Jun 2025filed 23 Jun 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —340,000 at $0.00 | filing |
| 18 Jun 2025filed 20 Jun 2025 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $5,0732,225 at $2.28 | filing |
| 11 Jun 2024filed 21 Jun 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —340,000 at $0.00 | filing |
| 7 Jun 2024filed 10 Jun 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $5,3002,500 at $2.12 | filing |
| 4 Jun 2024filed 5 Jun 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $5,9733,300 at $1.81 | filing |
| 20 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —194,218 | filing |
| 20 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —24,141 | filing |
| 20 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —24,141 | filing |
| 14 May 2024filed 14 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $10K4,500 at $2.23 | filing |
| 14 Aug 2023filed 9 Nov 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —293,000 at $0.00 | filing |
| 11 Aug 2023filed 14 Aug 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —193,000 at $0.00 | filing |
| 14 Nov 2022filed 15 Nov 2022 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $4,8885,200 at $0.94 | filing |
| 14 Jul 2022filed 18 Jul 2022 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.